Nasdaq

Milestone Pharmaceuticals Grants 113,000 Equity Awards to New Hires as Part of Inducement Plan

Milestone Pharmaceuticals Inc. announced the grant of 113,000 stock options to three new employees on January 2, 2025, as part of its 2021 Inducement Plan. The options, priced at $2.17 per share, will ...
equities

Milestone Shares More than Double After Presenting Updated Clinical Plan for Heart Condition

Shares of Milestone Pharmaceuticals traded 150% higher after the company reported regulatory guidance and updated its clinical development plan for etripamil nasal spray designed for self-administered ...
Seeking Alpha

Milestone Pharmaceuticals Announces Plan to Resubmit NDA for Etripamil for the Treatment of PSVT

MONTREAL and CHARLOTTE, N.C., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Milestone ® Pharmaceuticals Inc. (Nasdaq: MIST) today announced plans to resubmit the New Drug Application (NDA) for etripamil to the ...
Nasdaq

Milestone Pharmaceuticals Inc. Announces Investor Event for Commercial Launch Plan of Etripamil Nasal Spray CARDAMYST™

Milestone Pharmaceuticals announced a Commercial Launch Plan investor event, indicating proactive engagement with investors and transparency about its upcoming strategies. The event will detail the ...